Elisabetta Gazzerro Selected Research

Muscular Diseases (Myopathy)

1/2013	Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
7/2008	Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabetta Gazzerro Research Topics

Disease

7	Muscular Dystrophies (Muscular Dystrophy) 01/2023 - 07/2008
7	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 04/2010
5	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2023 - 03/2008
4	Inflammation (Inflammations) 01/2023 - 11/2018
4	5 Hypomyelinating Leukodystrophy 01/2012 - 10/2006
2	Sarcoglycanopathies 01/2023 - 01/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 08/2020
2	Muscular Diseases (Myopathy) 01/2013 - 07/2008
2	Multiple Myeloma 04/2010 - 05/2007
1	Fibrosis (Cirrhosis) 01/2022
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 08/2021
1	Myalgia 06/2018
1	Necrosis 01/2016
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 08/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2014
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 08/2014
1	Dementia (Dementias) 08/2014
1	Neutral Lipid Storage Disease with Myopathy 01/2013
1	Epilepsy (Aura) 03/2012
1	Intellectual Disability (Idiocy) 03/2012
1	Clinical Deterioration 06/2010
1	Heart Diseases (Heart Disease) 02/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2010
1	Distal Myopathies (Distal Muscular Dystrophy) 02/2010
1	1 Rippling muscle disease 02/2010
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2008
1	Metabolic Bone Diseases (Osteopenia) 01/2006
1	Neoplasms (Cancer) 01/2004
1	Breast Neoplasms (Breast Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 10/2006
4	Sarcoglycans (beta Sarcoglycan)IBA 01/2023 - 07/2008
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2019
3	DystrophinIBA 01/2019 - 07/2008
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2004
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2023 - 01/2018
2	EndocannabinoidsIBA 01/2023 - 01/2018
2	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 11/2018
2	Purinergic P2X7 ReceptorsIBA 01/2022 - 08/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 11/2018 - 06/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 04/2010
2	Bortezomib (Velcade)FDA Link 04/2010 - 05/2007
1	deflazacortIBA 01/2023
1	Volatile Fatty AcidsIBA 01/2023
1	Butyric Acid (Butanoic Acid)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021
1	InflammasomesIBA 08/2020
1	CannabidiolIBA 01/2019
1	ectoATPaseIBA 01/2019
1	AlarminsIBA 01/2019
1	cannabidivarinIBA 01/2019
1	Immunoglobulin G (IgG)IBA 11/2018
1	Zidovudine (Retrovir)FDA LinkGeneric 11/2018
1	UbiquitinIBA 01/2016
1	Ligases (Synthetase)IBA 01/2016
1	Tripartite Motif ProteinsIBA 01/2016
1	CeramidesIBA 08/2014
1	SphingolipidsIBA 08/2014
1	dihydroceramide desaturaseIBA 08/2014
1	Lipase (Acid Lipase)FDA Link 01/2013
1	LipidsIBA 01/2013
1	OsteopontinIBA 07/2012
1	Ion Channels (Ion Channel)IBA 03/2012
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 06/2010
1	Caveolin 3IBA 02/2010
1	Glycoproteins (Glycoprotein)IBA 07/2008
1	Aquaporin 4IBA 07/2008
1	Methionine (L-Methionine)FDA Link 03/2008
1	Threonine (L-Threonine)FDA Link 03/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2006
1	Retinoblastoma ProteinIBA 01/2004

Therapy/Procedure

2	Therapeutics 01/2023 - 08/2021
1	Palliative Care (Palliative Therapy) 01/2023
1	Aftercare (After-Treatment) 01/2019